2021
DOI: 10.1016/j.jinf.2020.11.034
|View full text |Cite
|
Sign up to set email alerts
|

Test on stool samples improves the diagnosis of hospitalized patients: Detection of SARS-CoV-2 genomic and subgenomic RNA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
18
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 10 publications
2
18
0
Order By: Relevance
“…Moreover, in contrast to the data reported by Alexandersen et al [ 17 ], who reported that the relative abundance of subgenomic RNAs may be more related to the sample’s quality and storage before the laboratory assay than to the actual stage of infection, we can emphasize that the persistence of sgN RNAs might be considered as a candidate biomarker of the active viral load, regardless of the pre-analytical conditions and analytical diagnostic kit. It is noteworthy that sgN was reported as the most expressed transcript in other sample types, like stool [ 19 ]; the authors of this research concluded that the detection of sgN and s gE improves the diagnosis of COVID-19, particularly in patients who are suspected of being infected but with negative results in the upper respiratory tract. Although the setting of this study [ 19 ] is different, we can agree with the authors’ conclusion, which emphasized the role of these subgenomic transcripts.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Moreover, in contrast to the data reported by Alexandersen et al [ 17 ], who reported that the relative abundance of subgenomic RNAs may be more related to the sample’s quality and storage before the laboratory assay than to the actual stage of infection, we can emphasize that the persistence of sgN RNAs might be considered as a candidate biomarker of the active viral load, regardless of the pre-analytical conditions and analytical diagnostic kit. It is noteworthy that sgN was reported as the most expressed transcript in other sample types, like stool [ 19 ]; the authors of this research concluded that the detection of sgN and s gE improves the diagnosis of COVID-19, particularly in patients who are suspected of being infected but with negative results in the upper respiratory tract. Although the setting of this study [ 19 ] is different, we can agree with the authors’ conclusion, which emphasized the role of these subgenomic transcripts.…”
Section: Discussionmentioning
confidence: 98%
“…It is noteworthy that sgN was reported as the most expressed transcript in other sample types, like stool [ 19 ]; the authors of this research concluded that the detection of sgN and s gE improves the diagnosis of COVID-19, particularly in patients who are suspected of being infected but with negative results in the upper respiratory tract. Although the setting of this study [ 19 ] is different, we can agree with the authors’ conclusion, which emphasized the role of these subgenomic transcripts. Our preliminary findings, although they were confirmed on a group of eighty-eight samples, should be deepened on larger cohorts, particularly to confirm the diagnostic potential of the sgN target in terms of the prediction of higher and active viral loads.…”
Section: Discussionmentioning
confidence: 98%
“…It is evident that the ratio of positive samples among patients in different studies varied greatly from 0 to 100% and 0 to 50% in stool and urine samples, respectively (Table S1). The presence of SARS-CoV-2 in stool and urine samples could be related to the swallowing of respiratory secretions from the upper respiratory tract or residues of infected antigen-presenting immune cells, or, more likely, due to virus replication in gastrointestinal epithelial cells or tubular epithelium [45] , [46] , [47] . Furthermore, the shedding magnitude detected in urine and stool samples varied from 10-10 4 copies/mL in urine samples and 10-10 8 copies/g in stool samples (Table S1).…”
Section: Key Uncertainties For Estimating Sars-cov-2 Prevalence‘mentioning
confidence: 99%
“…The tissue homogenate/ swab specimens were used for RNA extraction. MagMAX™ Viral/Pathogen Nucleic Acid Isolation Kit was used for viral RNA extraction and real-time RT-PCR was performed for E gene of SARS-CoV-2 and for N gene for the sub genomic (sg) RNA detection using the published primers [13, 14].…”
Section: Methodsmentioning
confidence: 99%